Sertraline Hcl Articles

New York parents charge Pfizer for concealing true risks of birth defects linked to Zoloft

7 May 2013

The “new” Pfizer sees 4th qtr s2009 sales and profit rocket, but 2010 guidance disappoints

4 February 2010

Generic drugs "saved USA $734B" since 1999, GPhA says, more than cost of TARP bank bail out

11 May 2009

Japan's MLHA calls for PI revisions for SSRIs and SNRI

11 May 2009

US brand name Rx drug prices rising, AARp study shows; PhRMA sees distortion

20 April 2009

CyDex Pharma IP to be auctioned

8 April 2009

Lexapro and Zoloft are "best" antidepressants

9 February 2009

US FTC closes, freezes assets of vast drug spam e-mail network

27 October 2008

Harmful drug-drug interactions for thyroid medicines identified

15 September 2008

Pfizer recovers from patent expiry slump with strong international sales in 2nd qtr

4 August 2008

Pfizer 1st-qtr income slumps 18%, hit by generic competition and acquisition costs

28 April 2008

New meta-analysis finds antidepressants are not effective for most people

10 March 2008

Japan's Chuikyo decides to cut NHI drug price for 11 active ingredients

11 February 2008

Lilly hits back at data suppression claims

28 January 2008

Pfizer sees 4th-qtr 2007 profits decline, but still beats forecasts; revenue rises 4%

28 January 2008

Global drug market to rise 5%-6% in 2008, shift away from developed markets

12 November 2007

US Rx drug market in relative decline

12 November 2007

Pfizer's 3rd-qtr suffers due to charges for dropping Exubera, generic competition

29 October 2007

Pfizer-Wyeth merger speculation fuels debate

3 September 2007

Pfizer

23 July 2007

Patent expiries threaten $22B of CNS drug sales, says URCH

18 June 2007

Nw drugs, obesity epidemic will drive US drug spending higher, says Medco

4 June 2007

US FDA to update black box warnings for young adults taking antidepressants

14 May 2007

New generics pose potential shake up for sleep drugs, antihypertensives in USA

12 March 2007

Pliva, Mylan and Actavis get US OK for generic Zoloft

12 February 2007

New class of antidepressants similar in efficacy but side effects differ, says AHRQ

5 February 2007

Dr Reddy's sees $350M sales in 4th-qtr 2006

5 February 2007

Dr Reddy's sees $350M sales in 4th-qtr 2006

5 February 2007

Patent expiries will stem growth of antidepressants market

18 December 2006

Pfizer's massive R&D spend to continue as firm pledges unprecedented innovation drive

11 December 2006

Pfizer to lose 20% of US sales force as it cuts costs

4 December 2006

More US firms push cheap drugs on workers

13 November 2006

US pharmacy benefit management firm launches generic plans

6 November 2006

Drug firms show innovation in dealing with patent expiry

31 July 2006

Pfizer's Zoloft launched in Japan, listed by NHI

17 July 2006

Pfizer makes plans to cope with generic competition for antidepressant Zoloft

10 July 2006

As blockbusters go generic, US health cost savings of $24.7B expected this year

12 June 2006

Eight new drugs added to Japan's NHI list by MHLW

5 June 2006

Health Canada warns about serious lung disorders linked to newer antidepressants

27 March 2006

Pfizer sees earnings down but beats expectations, and Lipitor still growing

30 January 2006

Danger to patients from weak US Rx system: CU

12 December 2005

USA

22 August 2005

Australian pharma warns over patent losses

22 August 2005

US FDA posts DSOB meeting summary

15 August 2005

Teva to regain No 1 generics spot with $7.4 acquisition of IVAX

1 August 2005

Pfizer sees 21% 2nd-qtr earnings growth, despite revenues rising just 1%

25 July 2005

Editor's view on "pill-splitting" and testing statins for cancer role

30 May 2005

French patent expiries to save1B euros by 2008

23 May 2005

EMEA warning over SSRIs, SNRIs in children

26 April 2005

Pfizer 1st-qtr sales strong but earnings slump on Bextra and other charges

25 April 2005

US workers' comp Rx costs rate of rise slows, but expensive new drugs boost spending

25 April 2005

US workers' comp Rx costs rate of rise slows, but expensive new drugs boost spending

22 April 2005

Combating generics: pharma brand defense

18 April 2005

Generic competition: early preparation "is a must"

7 February 2005

Pfizer prevails in Zoloft patent appeal by Teva

31 January 2005

Stron performance from Pfizer, as Lipitor becomes first "$10B product"

24 January 2005

US FDA advisers urge black box warning for antidepressant use in children

20 September 2004

Stock Commentary - New York

6 September 2004

Australian biotech and generics groups warn over AUSFTA amendments

30 August 2004

US FDA pediatric antidepressant use review update; public meeting Sept 13-14

30 August 2004

US FDA chief counsel accused over pharma

26 July 2004

Safety of antidepressants in children questioned again; Lancet study

3 May 2004

US FDA calls for black-box "suicide" warning on 10 antidepressants

29 March 2004

Global Rx sales up 9% in 2003, with US market rising 11%, reports IMS

29 March 2004

US Rx drug sales up 11.5% in 2003, growth sustained by new products, says IMS

23 February 2004

Appeals court upholds dismissal of law suit over Pfizer's Zoloft

23 February 2004

Bumper 4th-qtr/2003 sales at Pfizer, but acquisition costs drag on earnings

2 February 2004

Appeals court rules for Pfizer

5 January 2004

Positive new data for Forest's Lexapro

22 December 2003

Stock Commentary - New York

22 December 2003

Australia/US trade deal stumbles over PBS

15 December 2003

US market developments in 2002-3 and the rise of generics; CBI meeting

8 December 2003

Pfizer India hiving off older drugs

22 September 2003

Dr Reddy's Zoloft generic case dismissed in USA

21 July 2003

Pfizer boosted by disposals in 1st-qtr, double-digit sales and EPS growth

28 April 2003

McClellan says FDA will encourage generics but slams makers over approval delays

14 April 2003

2002 world pharma sales growth: slower but still healthy, says IMS

24 March 2003

Replace PIIP with R&D subsidiaries, says Australian Productivity Commission

24 February 2003

Effexor cleared for social phobia in USA

17 February 2003

Zoloft cleared in USA for social phobia

17 February 2003

Pfizer posts 46% rise in 4th qtr earnings on 14% higher blockbuster drug sales

27 January 2003

Setraline safe and effective for depression in ACS patients

19 August 2002

"Pfizer-Pharmacia," a behemoth is born, but does the market like it?

22 July 2002

Pfizer grows Japanese sales force in bid for top market spot

8 July 2002

Swedish pharma continues steady growth; 26.7bn kronor sales in 2001

8 July 2002

Pfizer grows Japanese sales force in bid for top market spot

8 July 2002

Zoloft cleared for PMDD in USA

27 May 2002

$22.5bn rise in US pharma sales in 2001; prescription drugs up 17.1%

6 May 2002

Pfizer 1st-qtr EPS increases 18%

22 April 2002

Californian pharmacists failing to offer Medi-Cal discounts, NEJM survey shows

25 March 2002

Pfizer sees earnings soar for 2001, as Lipitor sales continue to rise

28 January 2002

French pharma points to innovations

12 December 2001

Net income leaps 28% at Pfizer as Lipitor becomes world's best-selling drug

18 October 2001

Cipla signs deal with IVAX affiliate

5 September 2001

Pfizer gets FDA approval for Zoloft

24 August 2001

Zoloft receives FDA approval as first long-term PTSD treatment

22 August 2001

Update - Pfizer second-quarter net income leaps 31%

18 July 2001

Pfizer second-quarter net income leaps 31%; "never been stronger," says CEO

17 July 2001

2000 US Rx sales up 14.9% to $145 billion, with volume the main driver, says

4 June 2001

Pfizer 1st-qtr 2001 net income rises 34%

23 April 2001

Showing 1-100 of 197 articles

Go to beginningPreviousNextGo to end